Display options
Cite
Park JN, Schneider KE, Fowler D, et al. Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis. J Addict Med. 2021;doi: 10.1097/ADM.0000000000000823.
Park, J. N., Schneider, K. E., Fowler, D., Sherman, S. G., Mojtabai, R., & Nestadt, P. S. (2021). Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis. Journal of addiction medicine, . https://doi.org/10.1097/ADM.0000000000000823
Park, Ju Nyeong, et al. "Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis." Journal of addiction medicine vol. (2021). doi: https://doi.org/10.1097/ADM.0000000000000823
Park JN, Schneider KE, Fowler D, Sherman SG, Mojtabai R, Nestadt PS. Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis. J Addict Med. 2021 Mar 04; doi: 10.1097/ADM.0000000000000823. Epub 2021 Mar 04. PMID: 33675604; PMCID: PMC8417153.
Copy Download .nbib Format: NLM
Share it on

J Addict Med. 2021 Mar 04; doi: 10.1097/ADM.0000000000000823. Epub 2021 Mar 04.

Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis.

Journal of addiction medicine

Ju Nyeong Park, Kristin E Schneider, David Fowler, Susan G Sherman, Ramin Mojtabai, Paul S Nestadt

Affiliations

  1. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (JNP, SGS); Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (KES, RM, PSN); Office of the Chief Medical Examiner, Baltimore, MD (DF); Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (SGS); Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD (PSN).

PMID: 33675604 PMCID: PMC8417153 DOI: 10.1097/ADM.0000000000000823

Abstract

OBJECTIVES: To elucidate the main latent classes of substances detected among overdose decedents, and latent class associations with age, sex, race, and jurisdiction of death in Maryland.

METHODS: We used toxicology data from the Office of the Chief Medical Examiner of Maryland for all decedents. We analyzed all cases of drug overdose deaths that occurred from 2016 to 2018 (N = 6566) using latent class analysis and regression.

RESULTS: Drug overdose deaths were concentrated in 2 of 24 counties in Maryland (Baltimore City and County). Fentanyl was involved in 71% of all drug overdose deaths, and the majority (76%) of these deaths included multiple substances. Three latent classes emerged: (1) fentanyl/heroin/cocaine (64%); (2) fentanyl/alcohol (18%); and (3) prescription drugs including opioids, benzodiazepines and antidepressants (18.0%). The fentanyl/heroin/cocaine class members were significantly younger (<30 years), female and White compared to the fentanyl/alcohol class, but more male and non-White than the prescription drugs class (all P < 0.05). Deaths in Baltimore City/County were more likely than in other locations to involve fentanyl/alcohol (P < 0.05).

CONCLUSIONS: The majority of fentanyl-involved overdose deaths in Maryland involved multiple substances, and several demographic and geographic differences in these patterns emerged. Geographically-targeted interventions that are tailored to reduce the harms associated with polysubstance use (including cocaine, alcohol, and prescription drugs) for different demographic groups are warranted.

Copyright © 2021 American Society of Addiction Medicine.

References

  1. J Addict Dis. 2008;27(3):37-48 - PubMed
  2. Drug Alcohol Depend. 2017 Dec 1;181:58-62 - PubMed
  3. JAMA. 2018 May 1;319(17):1819-1821 - PubMed
  4. Int J Drug Policy. 2020 Mar;77:102661 - PubMed
  5. Harm Reduct J. 2018 Jul 5;15(1):34 - PubMed
  6. Pain Physician. 2016 May;19(4):215-28 - PubMed
  7. Drug Alcohol Depend. 2019 Nov 1;204:107592 - PubMed
  8. J Urban Health. 2019 Jun;96(3):353-366 - PubMed
  9. Alcohol Clin Exp Res. 2018 Mar;42(3):478-488 - PubMed
  10. Curr Opin Psychiatry. 2014 Jul;27(4):269-75 - PubMed
  11. J Psychoactive Drugs. 2018 Apr-Jun;50(2):167-176 - PubMed
  12. Public Health Rep. 2020 May/Jun;135(3):393-400 - PubMed
  13. Am J Prev Med. 2017 Dec;53(6):919-922 - PubMed
  14. Int J Drug Policy. 2017 Aug;46:107-111 - PubMed
  15. MMWR Morb Mortal Wkly Rep. 2019 Aug 09;68(31):687-688 - PubMed
  16. MMWR Morb Mortal Wkly Rep. 2019 Aug 30;68(34):737-744 - PubMed
  17. MMWR Morb Mortal Wkly Rep. 2019 May 03;68(17):388-395 - PubMed
  18. Drug Alcohol Rev. 2005 Sep;24(5):425-32 - PubMed
  19. Drug Alcohol Depend. 2004 Dec 7;76 Suppl:S11-9 - PubMed
  20. MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297 - PubMed
  21. Am J Public Health. 2017 Aug;107(8):1308-1310 - PubMed
  22. Drug Alcohol Depend. 2019 Dec 1;205:107671 - PubMed
  23. Milbank Q. 2020 Sep;98(3):700-746 - PubMed
  24. J Forensic Sci. 2019 Nov;64(6):1735-1742 - PubMed
  25. Am J Public Health. 2001 Nov;91(11):1842-6 - PubMed
  26. Addiction. 2014 Jan;109(1):79-87 - PubMed
  27. Int J Drug Policy. 2019 Jan;63:122-128 - PubMed
  28. Am J Public Health. 2017 Oct;107(10):1548-1553 - PubMed
  29. Drug Alcohol Depend. 2019 Aug 1;201:71-77 - PubMed
  30. Addiction. 2003 Jun;98(6):739-47 - PubMed
  31. Drug Alcohol Depend. 2016 Jan 1;158:132-8 - PubMed
  32. NCHS Data Brief. 2020 Jan;(356):1-8 - PubMed

Publication Types

Grant support